# DiaCare Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/diacare-medical

- Industry: Healthcare
- Headquarters: Nanchang, China
- Website: www.dakangmedical.com
- Total disclosed funding: $60M
- Latest round: Series E (Jun 29, 2022)
- Investors on record: 9

## About

Based in Jiangxi, China, and founded in 2012, DiaCare Medical operates as a blood purification medical service institution. It has 18 wholly-owned subsidiaries and has operated and built more than 100 independent blood purification centers and nephrology hospitals in Jiangxi, Shandong, Hebei, Henan, Shanxi, Hubei, Anhui, Guangdong, and other places. The group has nearly 1300 hemodialyses medical, nursing, and technical teams. In January 2024, the company closed a strategic investment from new investor Oct Capital.

The company's business can be categorized into health consulting services, medical research and experimental development, and hospital management. It sets up a chain of hemodialysis facilities and provides public assistance and medical dialysis services to uremic patients through its blood purification centers. DiaCare Medical provides this service based on hemoperfusion and hemodialysis technologies, as well as hemodialysis filtration machines.

The company will accelerate the pace of industry integration and promote the lock-in, scale and group development of independent hemodialysis centres in China.

## Funding rounds

- Series E, Jun 29, 2022, $60M — Neovision Capital, Central Enterprises Poor Regions Industry Investment Fund Co.,Ltd, Ganjiang New Area Innovation Industry Investment
- Series C, Sep 23, 2015 — CoStone Capital
- Series B, Jul 14, 2014 — CDH Investments, New Horizon Capital, Kaiwu Capital, CoStone Capital, Baichuan Huida Investment
- Series A, Jul 1, 2013 — New Vision Ventures
- Angel, Aug 8, 2012 — Kaiwu Capital

## Investors

- Kaiwu Capital (https://capitalatlas.ai/funds/kaiwu-capital) — Angel, Series B
- New Vision Ventures (https://capitalatlas.ai/funds/new-vision-ventures) — Series A
- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Series B
- New Horizon Capital — Series B
- CoStone Capital (https://capitalatlas.ai/funds/costone-capital) — Series B, Series C
- Baichuan Huida Investment (https://capitalatlas.ai/funds/baichuan-huida-investment) — Series B
- Neovision Capital (https://capitalatlas.ai/funds/neovision-capital) — Series E
- Central Enterprises Poor Regions Industry Investment Fund Co.,Ltd — Series E
- Ganjiang New Area Innovation Industry Investment — Series E